Dr. Agarwal's Health Care Limited (BOM:544350)
499.75
-3.25 (-0.65%)
At close: Aug 21, 2026
Dr. Agarwal's Health Care Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 158,555 | 128,798 | 140,835 | - | - | - | |
Market Cap Growth | 11.41% | -8.55% | - | - | - | - |
Enterprise Value | 167,322 | 135,537 | 146,808 | - | - | - |
Last Close Price | 499.75 | 406.15 | 446.90 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 106.86 | 96.70 | 168.75 | - | - | - |
PS Ratio | 7.19 | 6.19 | 8.23 | - | - | - |
PB Ratio | 7.48 | 6.08 | 7.31 | - | - | - |
P/TBV Ratio | 18.17 | 14.76 | 20.88 | - | - | - |
P/FCF Ratio | 223.19 | 181.30 | 290.50 | - | - | - |
P/OCF Ratio | 30.55 | 24.82 | 39.44 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 7.58 | 6.52 | 8.58 | - | - | - |
EV/EBITDA Ratio | 27.82 | 28.89 | 38.42 | - | - | - |
EV/EBIT Ratio | 52.22 | 46.22 | 63.84 | - | - | - |
EV/FCF Ratio | 235.53 | 190.79 | 302.82 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.50 | 0.50 | 0.50 | 0.70 | 1.30 | 2.71 |
Debt / EBITDA Ratio | 1.77 | 1.88 | 2.09 | 2.67 | 3.20 | 3.69 |
Debt / FCF Ratio | - | 15.01 | 19.82 | 8.40 | 11.20 | 6.73 |
Net Debt / Equity Ratio | 0.37 | 0.37 | 0.23 | 0.28 | 1.06 | 2.28 |
Net Debt / EBITDA Ratio | 1.56 | 1.67 | 1.17 | 1.29 | 3.20 | 3.82 |
Net Debt / FCF Ratio | - | 11.01 | 9.21 | 3.34 | 9.10 | 5.67 |
Asset Turnover | - | 0.55 | 0.53 | 0.58 | 0.71 | 0.77 |
Inventory Turnover | - | 13.55 | 14.93 | 17.43 | 16.99 | 13.24 |
Quick Ratio | - | 0.99 | 1.44 | 1.71 | 0.80 | 0.80 |
Current Ratio | - | 1.24 | 1.65 | 1.90 | 1.03 | 1.10 |
Return on Equity (ROE) | - | 8.31% | 6.67% | 9.32% | 23.12% | 19.96% |
Return on Assets (ROA) | - | 4.81% | 4.47% | 5.24% | 6.31% | 5.84% |
Return on Invested Capital (ROIC) | 7.56% | 7.52% | 7.67% | 8.32% | 13.57% | 9.34% |
Return on Capital Employed (ROCE) | - | 8.40% | 7.20% | 8.20% | 9.50% | 10.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.94% | 1.03% | 0.59% | - | - | - |
FCF Yield | 0.45% | 0.55% | 0.34% | - | - | - |
Payout Ratio | - | 0.82% | 0.95% | 0.93% | 0.46% | 0.02% |
Buyback Yield / Dilution | -3.13% | -6.19% | -13.09% | -12.46% | -14.56% | - |